First Edition: November 11, 2016
Today's early morning highlights from the major news organizations.
Archives: Morning Breakouts
35,521 - 35,540 of 112,572 Results
-
-
Viewpoints: Big Pharma’s Big Win; When Seniors Age At Home
A selection of opinions and editorials from around the country.
-
Perspectives On Obamacare’s Bleak Future And What Might Happen Next
Opinion and editorial writers examine what big changes in health policy might be ahead.
-
State Highlights: Va. Panel Recommends No Changes To Vaccine Exemptions; W.Va. Politics, Lawsuits Put Focus On Drug Distributors’ Role In Opioid Epidemic
Outlets report on health news from Virginia, West Virginia, Florida, Texas and Missouri.
By brilabuskes -
Decision Over Genetically Modified ‘Frankenflies’ Divides Florida Voters
The genetically altered mosquitoes would potentially help control the spread of Zika, but some voters made their concerns known via a non-binding "straw poll."
By brilabuskes -
Ballot Wins Help Galvanize Movement To Legalize Marijuana
Several states join a handful of others on Tuesday as they legalized either medical or recreational marijuana.
By brilabuskes -
Months Of Negotiations Over ‘Cures’ Bill Could Unravel In Light Of Trump Presidency
The package would have simplified the regulatory process of prescription drugs and medical devices and provided funding for health care innovation projects. However, its future is now uncertain.
By brilabuskes -
Mylan Reports 2 Federal Probes On Prices, Third-Quarter Loss After EpiPen Settlement
The company says the Securities and Exchange Commission is investigating its Medicaid rebates for the EpiPen while the Justice Department is looking into "marketing, pricing and sale" of generic medicines.
By brilabuskes -
FDA Mulls Plan For How Tweets Promoting Prescriptions Drugs Should Inform About Side Effects
The Food and Drug Administration also issues a rule aimed at curbing the use of citizen petitions for generic drugs or biosimilars. Some agency officials say the practice is used to slow down the approvals process.
By brilabuskes -
Pharma Stocks Reveal An Industry Breathing Sigh Of Relief Over Trump Win
Though Donald Trump's policies on high drug prices still remain a question mark, the industry is rallying on expectations of fewer regulations.
By brilabuskes -
Insurance Industry Reeling, Bracing For Total Upheaval After Election Surprise
Every part of the insurance industry could be affected by the policies Donald Trump and congressional Republicans have promised to enact.
By brilabuskes -
Backlash To Gutting Medicaid Could Complicate Promises To Dismantle ACA
Both Donald Trump and congressional Republicans want to shift Medicaid into a block-grant program, but that could mean many who received much-needed coverage under the health may lose their insurance.
By brilabuskes -
Across The Country, Election Results Raise Questions About Future Coverage Options
From Massachusetts to California, news outlets explore the implications of Republican plans to repeal the federal health law.
By brilabuskes -
Trump Likely To Target Vulnerable Pillars Of Health Law, But Portions May Be Here To Stay
Republican leaders say they are going to "hit the ground running" to start dismantling what they can of the Affordable Care Act. But after six years, there are aspects of the law now baked into the industry that won't be easy to upend.
By brilabuskes -
First Edition: November 10, 2016
Today's early morning highlights from the major news organizations.
By brilabuskes -
Viewpoints: How The Election Could Change Health Care; Calif. Voters Legalize Pot
A selection of opinions and editorials from around the country.
-
Perspectives: Mylan’s Not The Villain In EpiPen Controversy
Read recent commentaries about drug-cost issues.
By brilabuskes -
Government Has Known For Years Mylan Was Overcharging Medicaid For EpiPens
“The taxpayers deserve answers on what happened between 2009 and now,” Sen. Charles Grassley said.
By brilabuskes -
Pharma Company Blows Up Traditional Pricing Model To Provide Affordable Drugs
News outlets report on stories related to pharmaceutical drug pricing.
By brilabuskes -
Breakup Gets Uglier: Walgreens Sues Ex-Partner Theranos For $140M
The pharmacy company alleges that the blood-testing startup breached their contract.
By brilabuskes